1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase

α-Fluorinated-1,1-bisphosphonic acids derived from fatty acids were designed, synthesized and biologically evaluated against Trypanosoma cruzi, the etiologic agent of Chagas disease, and against Toxoplasma gondii, the agent responsible for toxoplasmosis, and also towards the target parasitic enzymes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Szajnman, S.H
Otros Autores: Rosso, V.S, Malayil, L., Smith, A., Moreno, S.N.J, Docampo, R., Rodriguez, J.B
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2012
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 13851caa a22017057a 4500
001 PAPER-9854
003 AR-BaUEN
005 20230518203950.0
008 190411s2012 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-84863012657 
024 7 |2 cas  |a geranyltransferase, 37277-79-5, 50812-36-7; 1-fluorononylidene-1,1-bisphosphonic acid; Antiprotozoal Agents; Diphosphonates; Enzyme Inhibitors; Geranyltranstransferase, 2.5.1.10 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
100 1 |a Szajnman, S.H. 
245 1 0 |a 1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase 
260 |c 2012 
270 1 0 |m Rodriguez, J.B.; Departamento de Química Orgánica and UMYMFOR (CONICET-FCEyN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón 2, C1428EHA, Buenos Aires, Argentina; email: jbr@qo.fcen.ar 
506 |2 openaire  |e Política editorial 
504 |a Roelofs, A.J., Thompson, K., Ebetino, F.H., Rogers, M.J., Coxon, F.P., (2010) Curr. Pharm. Des., 16, pp. 2950-2960 
504 |a Reszka, A.A., Rodan, G.A., (2004) Mini-Rev Med. Chem., 4, pp. 711-717 
504 |a Russell, R.G.G., Rogers, M.J., (1999) Bone, 25, pp. 97-106 
504 |a Reszka, A.A., Rodan, G.A., (2003) Curr. Osteoporosis Rep., 1, pp. 45-52 
504 |a Fleisch, H., Russell, R.G.G., Straumann, F., (1966) Nature, 212, pp. 901-903 
504 |a Fleisch, H., Russell, R.G.G., Francis, M.D., (1969) Science, 165, pp. 1262-1264 
504 |a Francis, M.D., Russell, R.G.G., Fleisch, H., (1969) Science, 165, pp. 1264-1266 
504 |a Urbina, J.A., Moreno, B., Vierkotter, S., Oldfield, E., Payares, G., Sanoja, C., Bailey, B.N., Docampo, R., (1999) J. Biol. Chem., 274, pp. 33609-33615 
504 |a Hughes, D.E., Wright, K.R., Uy, H.L., Sasaki, A., Yoneda, T., Roodman, G.D., Mundy, G.R., Boyce, B.F., (1995) J. Bone Miner. Res., 10, pp. 1478-1487 
504 |a Rogers, M.J., Frith, J.C., Luckman, S.P., Coxon, F.P., Benford, H.L., Mönkkönen, J., Auriola, S., Russell, R.G.G., (1999) Bone, 24, pp. 73S-79S 
504 |a Kavanagh, K.L., Guo, K., Dunford, J.E., Wu, X., Knapp, S., Ebetino, F.H., Rogers, M.J., Oppermann, U., (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 7829-7834 
504 |a Hosfield, D.J., Zhang, Y., Dougan, D.R., Broun, A., Tari, L.W., Swanson, R.V., Finn, J., (2004) J. Biol. Chem., 279, pp. 8526-8529 
504 |a Rondeau, J.-M., Bitsch, F., Bourgier, E., Geiser, M., Hemmig, R., Kroemer, M., Lehmann, S., Jahnke, W., (2006) ChemMedChem, 1, pp. 267-273 
504 |a Cheng, F., Oldfield, E., (2004) J. Med. Chem., 47, pp. 5149-5158 
504 |a Dunford, J.E., Thompson, K., Coxon, F.P., Luckman, S.P., Hahn, F.M., Poulter, C.D., Ebetino, F.H., Rogers, M.J., (2001) J. Pharmacol. Exp. Ther., 296, pp. 235-242 
504 |a Coxon, F.P., Thompson, K., Rogers, M.J., (2006) Curr. Opin. Pharmacol., 6, pp. 307-312 
504 |a Sanders, J.M., Ghosh, S., Chan, J.M.W., Meints, G., Wang, H., Raker, A.M., Song, Y., Oldfield, E., (2004) J. Med. Chem., 47, pp. 375-384 
504 |a Reddy, R., Dietrich, E., Lafontaine, Y., Houghton, T.J., Belanger, O., Dubois, A., Arhin, F.F., Rafai Far, A., (2008) ChemMedChem, 3, pp. 1863-1868 
504 |a Forlani, G., Giberti, S., Berlicki, Ł., Petrollino, D., Kafarski, P., (2007) J. Agric. Food Chem., 55, pp. 4340-4347 
504 |a Clézardin, P., Massaia, M., (2010) Curr. Pharm. Des., 16, pp. 3007-3014 
504 |a Miller, K., Erez, R., Segal, E., Shabat, D., Satchi-Fainaro, R., (2009) Angew. Chem., Int. Ed., 48, pp. 2949-2954 
504 |a Zhang, Y., Cao, R., Yin, F., Hudock, M.P., Guo, R.-T., Krysiak, K., Mukherjee, S., Oldfield, E., (2009) J. Am. Chem. Soc., 131, pp. 5153-5162 
504 |a Coleman, R.E., (2008) Br. J. Cancer, 98, pp. 1736-1740 
504 |a Roth, A.G., Drescher, D., Yang, Y., Redmer, S., Uhlig, S., Arenz, C., (2009) Angew. Chem., Int. Ed., 48, pp. 7560-7563 
504 |a Docampo, R., Moreno, S.N.J., (2008) Curr. Pharm. Des., 14, pp. 882-888 
504 |a Oldfield, E., (2010) Acc. Chem. Res., 43, pp. 1216-1226 
504 |a Ghosh, S., Chan, J.M.W., Lea, C.R., Meints, G.A., Lewis, J.C., Tovian, Z.S., Flessner, R.M., Oldfield, E., (2004) J. Med. Chem., 47, pp. 175-187 
504 |a Martin, M.B., Grimley, J.S., Lewis, J.C., Heath III, H.T., Bailey, B.N., Kendrick, H., Yardley, V., Oldfield, E., (2001) J. Med. Chem., 44, pp. 909-916 
504 |a Yardley, V., Khan, A.A., Martin, M.B., Slifer, T.R., Araujo Fausto, G., Moreno, S.N.J., Docampo, R., Oldfield, E., (2002) Antimicrob. Agents Chemother., 46, pp. 929-931 
504 |a Martin, M.B., Sanders, J.M., Kendrick, H., De Luca-Fradley, K., Lewis, J.C., Grimley, J.S., Van Brussel, E.M., Oldfield, E., (2002) J. Med. Chem., 45, pp. 2904-2914 
504 |a Rosso, V.S., Szajnman, S.H., Malayil, L., Galizzi, M., Moreno, S.N.J., Docampo, R., Rodriguez, J.B., (2011) Bioorg. Med. Chem., 19, pp. 2211-2217 
504 |a Szajnman, S.H., García Liñares, G.E., Li, Z.-H., Galizzi, M., Jiang, C., Bontempi, E., Ferella, M., Rodriguez, J.B., (2008) Bioorg. Med. Chem., 16, pp. 3283-3290 
504 |a Szajnman, S.H., Bailey, B.N., Docampo, R., Rodriguez, J.B., (2001) Bioorg. Med. Chem. Lett., 11, pp. 789-792 
504 |a Szajnman, S.H., Montalvetti, A., Wang, Y., Docampo, R., Rodriguez, J.B., (2003) Bioorg. Med. Chem. Lett., 13, pp. 3231-3235 
504 |a Szajnman, S.H., Ravaschino, E.L., Docampo, R., Rodriguez, J.B., (2005) Bioorg. Med. Chem. Lett., 15, pp. 4685-4690 
504 |a Ling, Y., Sahota, G., Odeh, S., Chan, J.M.W., Araujo, F.G., Moreno, S.N.J., Oldfield, E., (2005) J. Med. Chem., 48, pp. 3130-3140 
504 |a Bouzahzah, B., Jelicks, L.A., Morris, S.A., Weiss, L.M., Tanowitz, H.B., (2005) Parasitol. Res., 96, pp. 184-187 
504 |a García Liñares, G., Ravaschino, E.L., Rodriguez, J.B., (2006) Curr. Med. Chem., 13, pp. 335-360 
504 |a Urbina, J.A., Docampo, R., (2003) Trends Parasitol., 19, pp. 495-501 
504 |a Brener, Z., (1973) Annu. Rev. Microbiol., 27, pp. 347-382 
504 |a Moreno, S.N.J., Li, Z.-H., (2008) Expert Opinion. Ther. Targets, 12, pp. 253-263 
504 |a Levine, N.D., Corliss, J.O., Cox, F.E.G., Deroux, G., Grain, J., Honigberg, B.M., Leedale, G.F., Wallace, F.G., (1980) J. Protozool., 27, pp. 37-58 
504 |a Carruthers, V., Boothroyd, J.C., (2007) Curr. Opin. Microbiol., 10, pp. 83-89 
504 |a Fichera, M.E., Roos, D.S., (1997) Nature, 390, pp. 407-409 
504 |a Stokkermans, T.J.W., Schwartzman, J.D., Keenan, K., Morrissette, N.S., Tilney, L.G., Roos, D.S., (1996) Exp. Parasitol., 84, pp. 355-370 
504 |a Roberts, F., Roberts, C.W., Johnson, J.J., Kyle, D.E., Krell, T., Coggins, J.R., Coombs, G.H., McLeod, R., (1998) Nature, 393, pp. 801-805 
504 |a Urbina, J.A., (2010) Acta Tropica, 115, pp. 55-68 
504 |a Urbina, J.A., (2010) Drugs Fut, 35, pp. 409-420. , L. M. Amzel, personal communication 
504 |a Hosfield, D.J., Zhang, Y., Dougan, D.R., Broun, A., Tari, L.W., Swanson, R., Finn, J., (2003) J. Biol. Chem., 278, pp. 18401-18407 
504 |a Tarshis, L.C., Proteau, P.J., Kellogg, B.A., Sacchettini, J.C., Poulter, C.D., (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 15018-15023 
504 |a Huang, C.-H., Gabelli, S.B., Oldfield, E., Amzel, M.L., (2010) Proteins, 78, pp. 888-899 
504 |a Cao, R., Chen, C.K.-M., Guo, R.-T., Wang, A.H., Oldfield, E., (2008) Proteins, 73, pp. 431-439 
504 |a Gabelli, S.B., McLellan, J.S., Montalvetti, A., Oldfield, E., Docampo, R., Amzel, M.L., (2006) Proteins, 62, pp. 80-88 
504 |a Van Beek, E., Lowik, C., Que, I., Papapoulos, S., (1996) J. Bone Miner. Res., 11, pp. 1492-1497 
504 |a Ebetino, F.H., Francis, M.D., Rogers, M.J., Russell, R.G.G., (1998) Rev. Contemp. Pharmacother., 9, pp. 233-243 
504 |a Jung, A., Bisaz, S., Fleisch, H., (1973) Calcif. Tissue Res., 11, pp. 269-280 
504 |a Purser, S., Moore, P.R., Swallow, S., Gouverneur, V., (2008) Chem. Soc. Rev., 37, pp. 320-330 
504 |a Marma, M.S., Xia, Z., Stewart, C., Coxon, F., Dunford, J.E., Baron, R., Kashemirov, B.A., McKenna, C.E., (2007) J. Med. Chem., 50, pp. 5967-5975 
504 |a McKenna, C.E., Shen, P.-D., (1981) J. Org. Chem., 46, pp. 4573-4576 
504 |a Berkowitz, D.B., Bose, M., (2001) J. Fluorine Chem., 112, pp. 13-33 
504 |a Blackburn, G.M., England, D.A., Kolkmann, F., (1981) Chem. Commun., pp. 930-932 
504 |a Romanenko, V.D., Kukhar, V.P., (2006) Chem. Rev., 106, pp. 3868-3935 
504 |a De Schutter, J.W., Zaretsky, S., Welbourn, S., Pause, A., Tsantrizos, Y.S., (2010) Bioorg. Med. Chem. Lett., 20, pp. 5781-5786 
504 |a Lal, G.S., (1993) J. Org. Chem., 57, pp. 4676-4683 
504 |a Lal, G.S., Pez, G.P., Syvret, R.G., (1996) Chem. Rev., 96, pp. 1737-1755 
504 |a Xu, Y., Qian, Y.L., Prestwich, G.D., (2003) Org. Lett., 5, pp. 2267-2270 
504 |a Beier, P., Opekar, S., Mikhail Zibinsky, M., Inessa Bychinskaya, I., Prakash, G.K.S., (2011) Org. Biomol. Chem., 9, pp. 4035-4038 
504 |a Degenhardt, C.R., Burdsall, D.C., (1986) J. Org. Chem., 51, pp. 3488-3490 
504 |a Ling, Y., Li, Z.-H., Miranda, K., Oldfield, E., Moreno, S.N.J., (2007) J. Biol. Chem., 282, pp. 30804-30816 
504 |a Jeanmougin, F., Thompson, J.D., Gouy, M., Higgins, D.G., Gibson, T.J., (1998) Trends Biochem. Sciences, 23, pp. 403-405 
504 |a Canavaci, A.M., Bustamante, J.M., Padilla, A.M., Pereza Brandan, C.M., Simpson, L.J., Xu, D., Boehlke, C.L., Tarleton, R.L., (2010) PLOS Negl. Trop. Dis., 4, p. 740 
504 |a Gubbels, M.J., Li, C., Striepen, B., (2003) Antimicrob. Agents Chemother., 43, pp. 309-316 
504 |a Agrawal, S., Van Dooren, G.G., Beatty, W.L., Striepen, B., (2009) J. Biol. Chem., 284, pp. 33683-33691 
504 |a Ravaschino, E.L., Docampo, R., Rodriguez, J.B., (2006) J. Med. Chem., 49, pp. 426-435 
504 |a Montalvetti, A., Bailey, B.N., Martin, M.B., Severin, G.W., Oldfield, E., Docampo, R., (2001) J. Biol. Chem., 276, pp. 33930-33937 
504 |a Montalvetti, A., Fernandez, A., Sanders, J.M., Ghosh, S., Van Brussel, E., Oldfield, E., Docampo, R., (2003) J. Biol. Chem., 278, pp. 17075-17083 
504 |a Ogura, K., Nishino, T., Shinka, T., Seto, S., (1985) Methods Enzymol., 110, pp. 167-171 
520 3 |a α-Fluorinated-1,1-bisphosphonic acids derived from fatty acids were designed, synthesized and biologically evaluated against Trypanosoma cruzi, the etiologic agent of Chagas disease, and against Toxoplasma gondii, the agent responsible for toxoplasmosis, and also towards the target parasitic enzymes farnesyl pyrophosphate synthase of T. cruzi (TcFPPS) and T. gondii (TgFPPS). Interestingly, 1-fluorononylidene-1,1-bisphosphonic acid (compound 43) proved to be an extremely potent inhibitor of the enzymatic activity of TgFPPS at the low nanomolar range, exhibiting an IC 50 of 30 nM. This compound was two-fold more potent than risedronate (IC 50 = 74 nM) that was taken as a positive control. This enzymatic activity was associated with a strong cell growth inhibition against tachyzoites of T. gondii, with an IC 50 value of 2.7 μM. © 2012 The Royal Society of Chemistry.  |l eng 
593 |a Departamento de Química Orgánica and UMYMFOR (CONICET-FCEyN), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón 2, C1428EHA, Buenos Aires, Argentina 
593 |a Center for Tropical and Emerging Global Diseases, Department of Cellular Biology, University of Georgia, Athens, GA 30602, United States 
690 1 0 |a CHAGAS DISEASE 
690 1 0 |a ENZYMATIC ACTIVITIES 
690 1 0 |a ETIOLOGIC AGENTS 
690 1 0 |a FARNESYL PYROPHOSPHATES 
690 1 0 |a GROWTH INHIBITION 
690 1 0 |a NANOMOLAR RANGE 
690 1 0 |a POTENT INHIBITOR 
690 1 0 |a RISEDRONATE 
690 1 0 |a SELECTIVE INHIBITORS 
690 1 0 |a SYNTHASES 
690 1 0 |a TOXOPLASMA GONDII 
690 1 0 |a TRYPANOSOMA CRUZI 
690 1 0 |a CHEMISTRY 
690 1 0 |a POSITIVE IONS 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a 1 FLUORONONYLIDENE 1,1 BISPHOSPHONIC ACID 
690 1 0 |a 1-FLUORONONYLIDENE-1,1-BISPHOSPHONIC ACID 
690 1 0 |a ANTIPROTOZOAL AGENT 
690 1 0 |a BISPHOSPHONIC ACID DERIVATIVE 
690 1 0 |a ENZYME INHIBITOR 
690 1 0 |a GERANYLTRANSFERASE 
690 1 0 |a ARTICLE 
690 1 0 |a CHEMISTRY 
690 1 0 |a DRUG ANTAGONISM 
690 1 0 |a ENZYMOLOGY 
690 1 0 |a METABOLISM 
690 1 0 |a TOXOPLASMA 
690 1 0 |a ANTIPROTOZOAL AGENTS 
690 1 0 |a DIPHOSPHONATES 
690 1 0 |a ENZYME INHIBITORS 
690 1 0 |a GERANYLTRANSTRANSFERASE 
690 1 0 |a TOXOPLASMA 
690 1 0 |a TOXOPLASMA GONDII 
690 1 0 |a TRYPANOSOMA CRUZI 
700 1 |a Rosso, V.S. 
700 1 |a Malayil, L. 
700 1 |a Smith, A. 
700 1 |a Moreno, S.N.J. 
700 1 |a Docampo, R. 
700 1 |a Rodriguez, J.B. 
773 0 |d 2012  |g v. 10  |h pp. 1424-1433  |k n. 7  |p Org. Biomol. Chem.  |x 14770520  |w (AR-BaUEN)CENRE-2303  |t Organic and Biomolecular Chemistry 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863012657&doi=10.1039%2fc1ob06602a&partnerID=40&md5=ddfacfbeede2ce3d7a8c3b4b9a9dab1c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1039/c1ob06602a  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_14770520_v10_n7_p1424_Szajnman  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_14770520_v10_n7_p1424_Szajnman  |y Registro en la Biblioteca Digital 
961 |a paper_14770520_v10_n7_p1424_Szajnman  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 70807